A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.

Jucaite A, Öhd J, Potter AS, Jaeger J, Karlsson P, Hannesdottir K, Boström E, Newhouse PA, Paulsson B
Psychopharmacology (Berl). 2014 231 (6): 1251-65

PMID: 23640072 · PMCID: PMC3838503 · DOI:10.1007/s00213-013-3116-7

MeSH Terms (19)

Adult Attention Deficit Disorder with Hyperactivity Bridged Bicyclo Compounds, Heterocyclic Cognition Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Female Humans Male Middle Aged Neuropsychological Tests Nicotinic Agonists Psychiatric Status Rating Scales Receptors, Nicotinic Time Factors Tobacco Use Disorder Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: